Please login to the form below

Not currently logged in

Setback for AZ's MEK inhibitor selumetinib

AstraZeneca AZ

Drug fails at phase III in uveal melanoma

Sanofi and Regeneron extend partnership to cancer

Sanofi receptionSanofi will pay more than $2bn to the firm for immunotherapy research

Quarter of UK patients now diagnosing online

healthcare data technologyNew survey finds people would rather self-diagnose symptoms rather than wait for GP appointment

Teva buys Allergan generics unit for $40.5bn

Teva CopaxoneWill now drop its six-month pursuit of Mylan

Shire and Baxalta drugs among CHMP's latest recommendations

EU flagNew drugs for ADHD and haemophilia backed for European approval

Sanofi's cholesterol drug Praluent backed for European approval

Sanofi headquartersCHMP decision puts firm on-course to catch up with Amgen's Repatha

FDA approves four new medicines across multiple areas

FDA headquarters White OakSanofi/Regeneron, BMS, AbbVie and Novartis all chalk up major approvals

AZ sells rare cancer drug to Sanofi

AstraZeneca AZFrench firm’s rare disease unit Genzyme will pay $300m for the treatment

Lilly expands its San Diego biotech centre

Eli Lilly HQMove will create over 100 new drug discovery jobs

Jobs to do

Identifying opportunities and taking advantage of them

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Why tugging at our heartstrings is no longer enough to make us open our purses
Charlotte Shyllon (Director and Partner) and Maren Thurow (Senior Account Executive), discuss the highly emotive Make a Child Cry campaign video from Doctors of the World (Médecins du Monde)....
Exploring full potential of e-detailing data
Today’s high quality e-detailing data can create better quality conversations with healthcare professionals and result in improved access and relationships....
Understanding the "Big Picture"
In this article, Nic Talbot-Watt, Director of Analysis and Forecasting at Black Swan Analysis, highlights the advantage of having a robust commercial understanding of their healthcare innovation early in the...